-
1
-
-
0021149603
-
The development of human benign prostatic hyperplasia with age
-
S.J. Berry, D.S. Coffey, P.C. Walsh, and L.L. Ewing The development of human benign prostatic hyperplasia with age J Urol. 132 1984 474 479
-
(1984)
J Urol.
, vol.132
, pp. 474-479
-
-
Berry, S.J.1
Coffey, D.S.2
Walsh, P.C.3
Ewing, L.L.4
-
2
-
-
0027299554
-
The prevalence of prostatism: A population-based survey of urinary symptoms
-
C.G. Chute, L.A. Panser, C.J. Girman, J.E. Oesterling, H.A. Guess, and S.J. Jacobsen The prevalence of prostatism: a population-based survey of urinary symptoms J Urol. 150 1993 85 89
-
(1993)
J Urol.
, vol.150
, pp. 85-89
-
-
Chute, C.G.1
Panser, L.A.2
Girman, C.J.3
Oesterling, J.E.4
Guess, H.A.5
Jacobsen, S.J.6
-
3
-
-
0026643758
-
The relative proportion of stromal and epithelial hyperplasia as related to the development of clinical BPH
-
E. Shapiro, M.J. Berich, and H. Lepor The relative proportion of stromal and epithelial hyperplasia as related to the development of clinical BPH J Urol. 147 1992 1293 1297
-
(1992)
J Urol.
, vol.147
, pp. 1293-1297
-
-
Shapiro, E.1
Berich, M.J.2
Lepor, H.3
-
4
-
-
0031454617
-
Endostatin: An endogenous inhibitor of angiogenesis and tumour growth
-
M.S. O'Reilly, T. Boehm, Y. Shing, N. Fukai, G. Vasios, and W.S. Lane Endostatin: an endogenous inhibitor of angiogenesis and tumour growth Cell 88 1997 277 285
-
(1997)
Cell
, vol.88
, pp. 277-285
-
-
O'Reilly, M.S.1
Boehm, T.2
Shing, Y.3
Fukai, N.4
Vasios, G.5
Lane, W.S.6
-
5
-
-
0033597130
-
Endostatin induces endothelial cell apoptosis
-
M. Dhanabal, R. Ramchandran, M.J. Waterman, H. Lu, B. Knebelmann, and M. Segal Endostatin induces endothelial cell apoptosis J Biol Chem. 274 1999 11721 11726
-
(1999)
J Biol Chem.
, vol.274
, pp. 11721-11726
-
-
Dhanabal, M.1
Ramchandran, R.2
Waterman, M.J.3
Lu, H.4
Knebelmann, B.5
Segal, M.6
-
6
-
-
0033570910
-
Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin
-
T. Sasaki, H. Larsson, J. Kreuger, M. Salmivirta, L. Claesson-Welsh, and U. Lindahl Structural basis and potential role of heparin/heparan sulfate binding to the angiogenesis inhibitor endostatin EMBO J 18 1999 6240 6248
-
(1999)
EMBO J
, vol.18
, pp. 6240-6248
-
-
Sasaki, T.1
Larsson, H.2
Kreuger, J.3
Salmivirta, M.4
Claesson-Welsh, L.5
Lindahl, U.6
-
7
-
-
0030895268
-
Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: Comparison of normal and abnormal human tissue
-
A. Friedl, Z. Chang, A. Tierney, and A.C. Rapraeger Differential binding of fibroblast growth factor-2 and -7 to basement membrane heparan sulfate: comparison of normal and abnormal human tissue Am J Pathol. 150 1997 1443 1455
-
(1997)
Am J Pathol.
, vol.150
, pp. 1443-1455
-
-
Friedl, A.1
Chang, Z.2
Tierney, A.3
Rapraeger, A.C.4
-
8
-
-
0034575632
-
The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing
-
W. Bloch, K. Huggel, T. Sasaki, R. Grose, P. Bugnon, and K. Addicks The angiogenesis inhibitor endostatin impairs blood vessel maturation during wound healing FASEB J 14 2000 2373 2376
-
(2000)
FASEB J
, vol.14
, pp. 2373-2376
-
-
Bloch, W.1
Huggel, K.2
Sasaki, T.3
Grose, R.4
Bugnon, P.5
Addicks, K.6
-
9
-
-
0034682892
-
Genes expressed in human tumour endothelium
-
B. St Croix, C. Rago, V. Velculescu, G. Traverso, K.E. Romans, and E. Montgomery Genes expressed in human tumour endothelium Science. 289 2000 1197 1202
-
(2000)
Science.
, vol.289
, pp. 1197-1202
-
-
St Croix, B.1
Rago, C.2
Velculescu, V.3
Traverso, G.4
Romans, K.E.5
Montgomery, E.6
|